Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF and GM-CSF for Infection in Pediatric Cancer
NCT02933333Phase 4Unknown
- Sponsor
- Xinhua Hospital
- Start
- Sep 2016
- Primary completion
- Aug 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 4, randomised trial in Infection comparing GM-CSF, G-CSF and G-CSF + GM-CSF (3 arms). Primary endpoint: Incidence of infection at 20 days. Status: unknown.
02
Drugs
filgrastimsargramostim
03
Conditions
Infection
Beyond the preview
Go deeper on NCT02933333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933333.